January 27, 2017
BMS posts Q4 net profit, revenues driven by Opdivo sales up
Bristol-Myers Squib on Thursday posted fourth quarter net earnings of $1.1 billion, driven ly by increased sales of Opdivo and Eliquis.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
January 26, 2017
BD launches BD Institute for Medication Management Excellence
BD (Becton, Dickinson and Company) has launched its new BD Institute for Medication Management Excellence, developed to help advance the safe and efficient management of medication across the continuum of care.
January 26, 2017
FDA OK’s Ironwood/Allergan’s constipation drug
Ironwood Pharmaceuticals and Allergan have won U.S. Food and Drug Administration’s (FDA) approval for 72 mcg dose of Linzess (linaclotide) for the treatment of chronic idiopathic constipation (CIC) in adult patients.
January 26, 2017
AstraZeneca’s Symbicort for asthma available for 6-12 y.o. children in USA, FDA issues exclusivity rights
AstraZeneca’s Symbicort Inhalation Aerosol is going to be available for 6-12 years old children with asthma in the US
January 26, 2017
Novartis’s eye health division launches IOL
Alcon and a division of Novartis have launched AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery.
January 26, 2017
Advanced Oncotherapy welcomes Professor Steve Myers and Hans von Celsing as Non-Executive Directors
Advanced Oncotherapy has appointed Professor Steve Myers OBE and Hans von Celsing as Non-Executive Directors. Hans von Celsing will become Senior…
January 26, 2017
UPDATE: Johnson & Johnson buys Actelion for $30 billion
Johnson & Johnson said on Wednesday it will buy a Switzerland-based pharmaceutical company Actelion for $30 billion.
January 26, 2017
Ablynx, Merck KGaA report encouraging results from psoriasis treatment study
Ablynx and Merck KGaA (Germany) have reported encouraging results from a study in psoriasis patients with the bi-specific Nanobody anti-IL-17A/F (M1095), via a clinical trials website (https://clinicaltrials.gov/NCT02156466).
January 26, 2017
Sensorion receives €950,000 from Bpifrance and the Occitania Region
Bpifrance and the Occitania region of Southern France have selected to support Sensorion, a biotechnology company specializing in the treatment…
January 25, 2017
Potential Trump FDA Commissioner Choice: A Q&A With Dr. Joseph Gulfo
Here’s a lightly edited version of the interview with Dr. Joseph Gulfo, the executive director of the Lewis Center for Healthcare Innovation and Technology at Fairleigh Dickinson University, the author of “Innovation Breakdown: How the FDA and Wall Street Cripple Medical Advances” and the former President and CEO of the medical device firm MELA Sciences: